Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Quaini

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
The New England Journal of Medicine|May 13, 2011
Evidence for human lung stem cellsJan Kajstura, Marcello Rota, Sean R Hall, et al.
Frontiers in Bioscience (Elite Edition)|September 24, 2023
Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic ScoreGiulia Mazzaschi, Alessandro Lazzarin, Matteo Santoni, et al.
The Biochemical Journal|September 2, 2011
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21Roberta Possenti, Giampiero Muccioli, Pamela Petrocchi, et al.
Blood|May 19, 2026
Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic LeukemiaAnna Montanaro, Gregorio Monica, Raffaella Zamponi, et al.
Clinical & Experimental Metastasis|February 16, 2024
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinationsMichele Maffezzoli, Matteo Santoni, Giulia Mazzaschi, et al.
Cell Death & Disease|June 17, 2022
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemiaAnna Montanaro, Samuel Kitara, Elisa Cerretani, et al.
Immunotherapy|January 20, 2025
Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinationsMatilde Corianò, Alessandro Lazzarin, Michele Maffezzoli, et al.
Nature Communications|June 4, 2024
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AMLMatteo Marchesini, Andrea Gherli, Elisa Simoncini, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
The New England Journal of Medicine|May 13, 2011
Evidence for human lung stem cellsJan Kajstura, Marcello Rota, Sean R Hall, et al.
Frontiers in Bioscience (Elite Edition)|September 24, 2023
Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic ScoreGiulia Mazzaschi, Alessandro Lazzarin, Matteo Santoni, et al.
The Biochemical Journal|September 2, 2011
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21Roberta Possenti, Giampiero Muccioli, Pamela Petrocchi, et al.
Blood|May 19, 2026
Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic LeukemiaAnna Montanaro, Gregorio Monica, Raffaella Zamponi, et al.
Clinical & Experimental Metastasis|February 16, 2024
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinationsMichele Maffezzoli, Matteo Santoni, Giulia Mazzaschi, et al.
Cell Death & Disease|June 17, 2022
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemiaAnna Montanaro, Samuel Kitara, Elisa Cerretani, et al.
Immunotherapy|January 20, 2025
Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinationsMatilde Corianò, Alessandro Lazzarin, Michele Maffezzoli, et al.
Nature Communications|June 4, 2024
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AMLMatteo Marchesini, Andrea Gherli, Elisa Simoncini, et al.
Pageof 11